0 215

Cited 3 times in

The outcomes and risk factors of early readmission in patients with intestinal Behcet's disease

DC FieldValueLanguage
dc.contributor.author김원호-
dc.contributor.author김태일-
dc.contributor.author박수정-
dc.contributor.author박예현-
dc.contributor.author박용은-
dc.contributor.author천재희-
dc.contributor.author김태일-
dc.contributor.author박수정-
dc.contributor.author박예현-
dc.contributor.author박용은-
dc.contributor.author천재희-
dc.date.accessioned2019-03-15T02:28:06Z-
dc.date.available2019-03-15T02:28:06Z-
dc.date.issued2018-
dc.identifier.issn0770-3198-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/167498-
dc.description.abstractHospital readmission rate is an integral quality of care measurement for hospitalized patients which is unknown for intestinal Behçet's disease cases. The purpose of this study was to investigate the risk factors and outcomes for patients readmitted early with intestinal Behçet's disease. We retrospectively reviewed patients with intestinal Behçet's disease who were readmitted to our hospital between 2005 and 2016. We then analyzed the risk factors and outcomes for early readmission within 3 months. Of the 204 patients who were readmitted, 103 patients (50.5%) were readmitted within 3 months and 101 (49.5%) were never readmitted or readmitted after 3 months. After multivariate analysis, hospital stay at the first admission (adjusted odds ratio [OR], 0.945; 95% confidence interval [CI], 0.908-0.982; P = 0.004), high disease activity index for intestinal Behçet's disease score (adjusted OR, 1.111; 95% CI, 1.060-1.165; P < 0.001), corticosteroid use (adjusted OR, 3.179; 95% CI, 1.135-8.910; P = 0.028), and opioid use (adjusted OR, 7.979; 95% CI, 1.084-58.755; P = 0.041) were independent factors for early readmission. We identified four independent prognostic factors for early readmission within 3 months, which might help guide appropriate management strategies for hospitalized patients with intestinal Behçet's disease.-
dc.description.statementOfResponsibilityrestriction-
dc.languageEnglish-
dc.publisherSpringer-
dc.relation.isPartOfCLINICAL RHEUMATOLOGY-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.subject.MESHAdrenal Cortex Hormones/therapeutic use-
dc.subject.MESHAnalgesics, Opioid/therapeutic use-
dc.subject.MESHBehcet Syndrome/drug therapy-
dc.subject.MESHBehcet Syndrome/epidemiology*-
dc.subject.MESHHumans-
dc.subject.MESHIntestinal Diseases/drug therapy-
dc.subject.MESHIntestinal Diseases/epidemiology*-
dc.subject.MESHLength of Stay-
dc.subject.MESHMultivariate Analysis-
dc.subject.MESHPatient Readmission*-
dc.subject.MESHQuality of Health Care-
dc.subject.MESHRepublic of Korea/epidemiology-
dc.subject.MESHRetrospective Studies-
dc.subject.MESHRisk Factors-
dc.subject.MESHTime Factors-
dc.subject.MESHTreatment Outcome-
dc.titleThe outcomes and risk factors of early readmission in patients with intestinal Behcet's disease-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학교실)-
dc.contributor.googleauthorYong Eun Park-
dc.contributor.googleauthorJae Hee Cheon-
dc.contributor.googleauthorYehyun Park-
dc.contributor.googleauthorSoo Jung Park-
dc.contributor.googleauthorTae Il Kim-
dc.contributor.googleauthorWon Ho Kim-
dc.identifier.doi10.1007/s10067-017-3904-2-
dc.contributor.localIdA00774-
dc.contributor.localIdA01079-
dc.contributor.localIdA01079-
dc.contributor.localIdA01539-
dc.contributor.localIdA01539-
dc.contributor.localIdA01575-
dc.contributor.localIdA01575-
dc.contributor.localIdA04571-
dc.contributor.localIdA04571-
dc.contributor.localIdA04030-
dc.contributor.localIdA04030-
dc.contributor.localIdA01079-
dc.contributor.localIdA01079-
dc.contributor.localIdA01539-
dc.contributor.localIdA01539-
dc.contributor.localIdA01575-
dc.contributor.localIdA01575-
dc.contributor.localIdA04571-
dc.contributor.localIdA04571-
dc.contributor.localIdA04030-
dc.contributor.localIdA04030-
dc.relation.journalcodeJ00612-
dc.identifier.eissn1434-9949-
dc.identifier.pmid29116542-
dc.identifier.urlhttps://link.springer.com/article/10.1007%2Fs10067-017-3904-2-
dc.subject.keywordIntestinal Behçet’s disease-
dc.subject.keywordPrognostic factor-
dc.subject.keywordReadmission-
dc.contributor.alternativeNameKim, Won Ho-
dc.contributor.affiliatedAuthor김원호-
dc.contributor.affiliatedAuthor김태일-
dc.contributor.affiliatedAuthor김태일-
dc.contributor.affiliatedAuthor박수정-
dc.contributor.affiliatedAuthor박수정-
dc.contributor.affiliatedAuthor박예현-
dc.contributor.affiliatedAuthor박예현-
dc.contributor.affiliatedAuthor박용은-
dc.contributor.affiliatedAuthor박용은-
dc.contributor.affiliatedAuthor천재희-
dc.contributor.affiliatedAuthor천재희-
dc.contributor.affiliatedAuthor김태일-
dc.contributor.affiliatedAuthor김태일-
dc.contributor.affiliatedAuthor박수정-
dc.contributor.affiliatedAuthor박수정-
dc.contributor.affiliatedAuthor박예현-
dc.contributor.affiliatedAuthor박예현-
dc.contributor.affiliatedAuthor박용은-
dc.contributor.affiliatedAuthor박용은-
dc.contributor.affiliatedAuthor천재희-
dc.contributor.affiliatedAuthor천재희-
dc.citation.volume37-
dc.citation.number7-
dc.citation.startPage1913-
dc.citation.endPage1920-
dc.identifier.bibliographicCitationCLINICAL RHEUMATOLOGY, Vol.37(7) : 1913-1920, 2018-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.